ACADIAN ASSET MANAGEMENT LLC

Position in HRMY — Harmony Biosciences Holdings, Inc.

CIK 916542 Boston, MA

Position in HRMY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$7,842,714

+$4,180,435 QoQ

Shares Held

215,400

+64.7% QoQ

Ownership

0.370%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#45

of 328 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names. HRMY ranks #22 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,664,999	$188,744,286
2	REGN	Regeneron Pharmaceuticals, Inc.	157,440	$98,170,137
3	IMCR	Immunocore Holdings plc	1,209,894	$38,414,134
4	RIGL	Rigel Pharmaceuticals Inc	591,686	$23,146,756
5	EXEL	Exelixis, Inc.	421,444	$22,930,768
6	VRTX	Vertex Pharmaceuticals Inc / Ma	42,122	$20,923,261
7	TBPH	Theravance Biopharma, Inc.	1,174,910	$19,973,470
8	PRTA	Prothena Corp Public Ltd Co	2,010,645	$19,684,214

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,842,714	215,400	+64.7%	Shares	Defined	2026-08-13
2026-03-31	$3,662,279	130,749	+480.1%	Shares	Defined	2026-05-13
2025-12-31	$843,446	22,540	-53.2%	Shares	Defined	2026-02-10
2025-09-30	$1,328,474	48,203	+117.4%	Shares	Defined	2025-11-13
2025-06-30	$700,793	22,177	-84.0%	Shares	Defined	2025-08-07
2025-03-31	$4,595,985	138,475	+2773.5%	Shares	Defined	2025-05-21
2024-09-30	$192,760	4,819	+76.9%	Shares	Defined	2024-11-12
2022-09-30	$120,645	2,724	0.0%	Shares	Defined	2022-11-14
2022-06-30	$132,849	2,724	-19.1%	Shares	Defined	2022-08-09
2022-03-31	$163,804	3,367	+69.7%	Shares	Defined	2022-05-12
2021-12-31	$84,597	1,984	—	Shares	Defined	2022-02-10
No filing history on record for this holder in this stock.